EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

External Validation of PET Radiomics-Based ML Model for Non-Invasive Lung Cancer Subtype Classification

Pooja Dwivedi, Sagar Barage, Ashish Kumar Jha, Archi Agrawal, Venkatesh Rangarajan

Biomedical & Pharmacology Journal · 21.03.2026 · 1 (19) · 625

DOI: 10.13005/bpj/3380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical & Pharmacology Journal, online erschienen am 20.03.2026. Verfasst von Pooja Dwivedi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Independent validation is critical in radiomic research to mitigate bias and enhance clinical translatability. This study presents the development and external validation of a PET (Positron Emission Tomography) radiomics-based machine learning (ML) model for the non-invasive classification of non-small cell lung cancer (NSCLC) histological subtypes, adenocarcinoma and squamous cell carcinoma, and evaluates its clinical utility. Adhering to the CLEAR radiomics reporting guidelines, two retrospective PET datasets from different institutions were employed: one for model training and the other for external validation. Tumor segmentation was performed using a 40% SUVmax threshold, followed by radiomic feature extraction using IBSI-compliant software and ComBat harmonization. To address class imbalance, appropriate resampling techniques were applied, and recursive feature elimination identified the top five predictive features. Three ML models were trained and evaluated on unseen external data. Model performance was compared using Delong’s test, and clinical utility was assessed via decision and clinical impact curve analyses. The XGB model demonstrated superior performance with an accuracy of 80% and an AUC of 0.82 [95% CI: 0.73–0.91], along with favourable calibration (Brier score: 0.12). Decision curve analysis confirmed its net clinical benefit. These findings underscore the clinical relevance of PET radiomics combined with advanced ML techniques, offering a robust, non-invasive tool for histological subtype classification in NSCLC. The externally validated model demonstrates strong potential for integration into translational oncological workflows, aiding personalized treatment planning and improving diagnostic precision in real-world settings.

Zitieren

APA

Dwivedi, P., Barage, S., Jha, A. K., Agrawal, A., & Rangarajan, V. (2026). External Validation of PET Radiomics-Based ML Model for Non-Invasive Lung Cancer Subtype Classification. Biomedical & Pharmacology Journal, 1(19), 625. https://doi.org/10.13005/bpj/3380

Vancouver

Dwivedi P, Barage S, Jha AK, Agrawal A, Rangarajan V. External Validation of PET Radiomics-Based ML Model for Non-Invasive Lung Cancer Subtype Classification. Biomedical & Pharmacology Journal. 2026;1(19):625. doi:10.13005/bpj/3380

BibTeX
@article{Dwivedi2026,
  author = {Dwivedi, Pooja and Barage, Sagar and Jha, Ashish Kumar and Agrawal, Archi and Rangarajan, Venkatesh},
  title = {External Validation of PET Radiomics-Based ML Model for Non-Invasive Lung Cancer Subtype Classification},
  journal = {Biomedical & Pharmacology Journal},
  year = {2026},
  volume = {1},
  number = {19},
  pages = {625},
  doi = {10.13005/bpj/3380}
}
Kostenlos starten →